EP1862852A1 - Developer concentrate - Google Patents
Developer concentrate Download PDFInfo
- Publication number
- EP1862852A1 EP1862852A1 EP07010793A EP07010793A EP1862852A1 EP 1862852 A1 EP1862852 A1 EP 1862852A1 EP 07010793 A EP07010793 A EP 07010793A EP 07010793 A EP07010793 A EP 07010793A EP 1862852 A1 EP1862852 A1 EP 1862852A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- concentrate according
- developer concentrate
- amount
- per liter
- working solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
- G03C5/264—Supplying of photographic processing chemicals; Preparation or packaging thereof
- G03C5/266—Supplying of photographic processing chemicals; Preparation or packaging thereof of solutions or concentrates
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
- G03C5/29—Development processes or agents therefor
- G03C5/30—Developers
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
- G03C5/29—Development processes or agents therefor
- G03C5/30—Developers
- G03C2005/3007—Ascorbic acid
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C2200/00—Details
- G03C2200/44—Details pH value
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
- G03C5/29—Development processes or agents therefor
- G03C5/30—Developers
- G03C5/3028—Heterocyclic compounds
- G03C5/3035—Heterocyclic compounds containing a diazole ring
Definitions
- the invention relates to a developer for photosensitive film material according to the preamble of claim 1.
- Such developers are in a variety of forms on the market. They generally serve to convert, by a reducing agent (developing agent), silver ions or other suitable metal ions contained in the photosensitive layer and sensitized by exposure to light into metallic silver.
- a reducing agent developer agent
- silver ions or other suitable metal ions contained in the photosensitive layer and sensitized by exposure to light into metallic silver.
- the present invention is intended to provide a developer concentrate for photosensitive film material, which is distinguished by particularly good long-term stability under use conditions.
- the developer according to the invention has as further advantages that it is free of hydroquinone and of GDA (glutaraldehyde adduct). It is also characterized by a very high development activity. It also has excellent yield, especially in roll developing machines.
- the most important component in terms of quantity is the solvent. This is generally chosen so that it is compatible with the film layer to be developed, so it wets and allows an exchange of solutes with the film layer.
- a water-based solvent is suggested, which means that this solvent comprises predominantly or completely water.
- adjuvants may be added to the water which promote wetting of the film layer, optionally swelling of the film layer and later drying of the film layer.
- the developing agent serves to convert the metal ions of the photosensitive layer, insofar as they have been activated by light, into elemental metal.
- known developing agents include hydroquinone and other substances that are undesirable for environmental or potential health reasons.
- One class of reducing agent used in the developer of the present invention includes ascorbic acid and derivatives of ascorbic acid, especially salts thereof. These are particularly advantageous in terms of environmental protection.
- Development enhancers used in the invention include pyrazolidinone derivatives containing two nitrogen atoms in a five-membered ring.
- the five-membered ring may carry further aliphatic or aromatic groups.
- Preferred examples of such pyrazolidinone derivative developing agents are 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidinone, 1-phenylpyrazolidin-3-one and 1-phenyl-4-methyl-3-pyrazolidinone. These substances are also known under the trade names Dimezone S, Phenidone A and Phenidone B.
- a development inhibitor is added to the developer.
- These are preferably alkali halides, in particular those with heavier anions, preferably potassium bromide or sodium bromide.
- the pH of the use solution be maintained within a given window of from about 8.5 to about 12, preferably from about 9.7 to about 11.2.
- alkalis preferably potassium hydroxide or sodium hydroxide.
- the pH can also be stabilized by salts of a weak acid in the desired alkaline range, in particular salts of weak organic or inorganic acids, preferably potassium carbonate, sodium tetraborate, sodium metaborate. You can also use mixtures of alkalis and salts.
- the development result is advantageously influenced if the developer is additionally added a complexing agent.
- complexing agents are preferably organic acids with small chain length, which contain nitrogen groups, more preferably additionally short aliphatic groups.
- Preferred complexing agents are diethyltriamine pentaethanoic acid (DTPA), ethylenediaminetetraethanoic acid (EDTA), hydroxyethylethylenediaminetriacetic acid (HEDTA) and nitrilotriethanoic acid (NTA) and salts of the aforementioned acids.
- a ready-to-use developer solution is adversely affected by oxidation in its properties.
- an antioxidant to the developer.
- Suitable for this purpose are generally not completely oxidized acids and salts thereof, in particular sulfites such as potassium sulfite, potassium hydrogen sulfite, potassium metabisulfite and sodium bisulfite.
- a solubilizer can be used.
- These may be polyhydric alcohols, in particular diols or glycols. Diethylene glycol and triethylene glycol are preferably used here.
- agents belonging to the group of azoles in particular of the benzotriazole, indazole, mercaptotetrazole and imidazole type), in particular 5-mercapto-1-phenyl-1,2,3,4-tetrazole (PMT ), 1-H-benzotriazole, 5-methylbenzotriazole, 6-nitrobenzimidazole, 5-nitroindazole.
- compositions of embodiments give an overview of the concentration in which the various components in a Use solution in grams per liter of working solution may be present.
- the concentrations are recommended, which are recommended if a considered component alone forms the corresponding agent. It is understood that it is also possible to use mixtures of substances that are equally suitable for the same component of the developer, in which case the amounts used are selected such that the corresponding overall effect is obtained. Thus, for example, according to the following table for the different complexing agents in each case the same amount used. In this case, one can then simply replace the omitted portion of a complexing agent with an appropriate amount of another complexing agent.
- Example 1 Developer for X-ray film processor
- concentration data in the above description and claims refer, as indicated, to one liter of working solution and not to the concentrate.
- concentrations in the concentrate are greater according to the prescribed dilution ratio for the concentrate. This dilution ratio is about 1.5 to 5 for a practical developer for roll-fed development machines, and about 0.5 to 1 for roll-free processors (film is moved around the edges by the tanks).
Abstract
Description
Die Erfindung betrifft einen Entwickler für lichtempfindliches Filmmaterial gemäß dem Oberbegriff des Anspruches 1.The invention relates to a developer for photosensitive film material according to the preamble of claim 1.
Derartige Entwickler sind in vielfältiger Form auf dem Markt. Sie dienen generell dazu, durch ein Reduktionsmittel (Entwicklungsmittel) Silberionen oder andere geeignete Metallionen, die in der lichtempfindlichen Schicht enthalten sind und durch Lichteinwirkung sensibilisiert sind, in metallisches Silber umwandelt.Such developers are in a variety of forms on the market. They generally serve to convert, by a reducing agent (developing agent), silver ions or other suitable metal ions contained in the photosensitive layer and sensitized by exposure to light into metallic silver.
Bei Entwicklern, die in Entwicklungsautomaten verwendet werden, die große Volumina an Entwicklern enthalten, stellt sich das Problem der Langzeitstabilität des gebrauchsfertigen Entwicklers ohne Regenerierung. Nach Standzeiten von einigen Tagen oder Wochen lässt die Entwicklungsqualität deutlich nach und der gesamte Entwickler muss durch neuen Entwickler ersetzt werden.For developers used in development machines that contain large volumes of developers, the problem of the long-term stability of the ready-to-use developer without regeneration arises. After a service life of a few days or weeks, the development quality decreases significantly and the entire developer must be replaced by new developers.
Durch die vorliegende Erfindung soll ein Entwicklerkonzentrat für lichtempfindliches Filmmaterial geschaffen werden, welches sich durch besonders gute Langzeitstabilität unter Einsatzbedingungen auszeichnet.The present invention is intended to provide a developer concentrate for photosensitive film material, which is distinguished by particularly good long-term stability under use conditions.
Diese Aufgabe ist erfindungsgemäß gelöst durch einen Entwickler mit den in Anspruch 1 angegebenen Merkmalen.This object is achieved by a developer having the features specified in claim 1.
Der erfindungemäße Entwickler hat als weitere Vorteile, dass er frei von Hydrochinon und von GDA (Glutardialdehydaddukt) ist. Er zeichnet sich auch durch eine sehr hohe Entwicklungsaktivität aus. Er hat auch eine ausgezeichnete Ergiebigkeit, insbesondere in Rollen-Entwicklungsmaschinen.The developer according to the invention has as further advantages that it is free of hydroquinone and of GDA (glutaraldehyde adduct). It is also characterized by a very high development activity. It also has excellent yield, especially in roll developing machines.
Vorteilhafte Weiterbildungen der Erfindung sind Gegenstand der Unteransprüche.Advantageous developments of the invention are the subject of the dependent claims.
Nachstehend werden zu einzelnen Komponenten eines erfindungsgemäßen Entwicklerkonzentrates, welche in diesem enthalten sein können, allgemeine Anmerkungen gegeben.Hereinbelow, general comments will be made on individual components of a developer concentrate of the invention which may be included therein.
Mengenmäßig die wichtigste Komponente ist das Lösungsmittel. Dieses ist generell so gewählt, dass es mit der zu entwickelnden Filmschicht kompatibel ist, also diese benetzt und einen Austausch gelöster Stoffe mit der Filmschicht ermöglicht. Es wird ein Lösungsmittel auf Wasserbasis vorgeschlagen, was bedeutet, dass dieses Lösungsmittel überwiegend oder ganz Wasser umfasst. Dem Wasser können jedoch Hilfsstoffe zugefügt sein, welche die Benetzung der Filmschicht, gegebenenfalls ein Quellen der Filmschicht und später ein Trocknen der Filmschicht begünstigen.The most important component in terms of quantity is the solvent. This is generally chosen so that it is compatible with the film layer to be developed, so it wets and allows an exchange of solutes with the film layer. A water-based solvent is suggested, which means that this solvent comprises predominantly or completely water. However, adjuvants may be added to the water which promote wetting of the film layer, optionally swelling of the film layer and later drying of the film layer.
Das Entwicklungsmittel dient, wie üblich, dazu, die Metallionen der lichtempfindlichen Schicht, soweit sie durch Licht aktiviert wurden, in elementares Metall umzuwandeln. Bekannte Entwicklungsmittel umfassen zum Beispiel Hydrochinon und andere Substanzen, die aus Gründen des Umweltschutzes oder potentieller gesundheitlicher Gefährdung nicht erwünscht sind.The developing agent, as usual, serves to convert the metal ions of the photosensitive layer, insofar as they have been activated by light, into elemental metal. For example, known developing agents include hydroquinone and other substances that are undesirable for environmental or potential health reasons.
Eine Klasse beim erfindungsgemäßen Entwickler verwendeter Reduktionsmittel umfasst Ascorbinsäure und Derivate der Ascorbinsäure, insbesondere Salze derselben. Diese sind im Hinblick auf den Umweltschutz besonders vorteilhaft.One class of reducing agent used in the developer of the present invention includes ascorbic acid and derivatives of ascorbic acid, especially salts thereof. These are particularly advantageous in terms of environmental protection.
Bei der Erfindung verwendete Entwicklungsverstärker umfassen Pyrazolidinon-Derivate, die in einem Fünfring zwei Stickstoffatome enthalten. Der Fünferring kann weitere aliphatische oder aromatische Gruppen tragen.Development enhancers used in the invention include pyrazolidinone derivatives containing two nitrogen atoms in a five-membered ring. The five-membered ring may carry further aliphatic or aromatic groups.
Bevorzugte Beispiele für derartige Pyrazolidinonderivat-Entwicklungsmittel sind 4-Hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidinon, 1-Phenylpyrazolidin-3-on und 1-Phenyl-4-methyl-3-pyrazolidinon. Diese Substanzen sind auch unter den Handelsnamen Dimezone S, Phenidon A und Phenidon B bekannt.Preferred examples of such pyrazolidinone derivative developing agents are 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidinone, 1-phenylpyrazolidin-3-one and 1-phenyl-4-methyl-3-pyrazolidinone. These substances are also known under the trade names Dimezone S, Phenidone A and Phenidone B.
Die Vorteile dieser Substanzen liegen in einer intensiveren Schwärzung der belichteten Filmbereiche (Superadditivität).The advantages of these substances lie in a more intense blackening of the exposed film areas (superadditivity).
Legt man größeren Wert auf die Qualität und die Gleichförmigkeit des Entwicklungsergebnisses als auf die Kürze des Entwicklungsprozesses, so wird dem Entwickler ein Entwicklungsverzögerer zugesetzt. Es handelt sich hierbei bevorzugt um Alkalihalogenide, insbesondere solche mit schwereren Anionen, bevorzugt Kaliumbromid oder Natriumbromid.If more emphasis is placed on the quality and uniformity of the development result than on the brevity of the development process, a development inhibitor is added to the developer. These are preferably alkali halides, in particular those with heavier anions, preferably potassium bromide or sodium bromide.
Für die Langzeitstabilität des Entwicklers ist es von großer Bedeutung, dass der pH-Wert der Gebrauchslösung innerhalb eines vorgegebenen Fensters von etwa 8.5 bis etwa 12 gehalten wird, vorzugsweise von etwa 9,7 bis etwa 11,2.For the long-term stability of the developer, it is of great importance that the pH of the use solution be maintained within a given window of from about 8.5 to about 12, preferably from about 9.7 to about 11.2.
Man kann hierzu zum einen einfach Laugen verwenden, bevorzugt Kaliumhydroxid oder Natriumhydroxid. Man kann den pH-Wert aber auch durch Salze einer schwachen Säure im gewünschten alkalischen Bereich stabilisieren, insbesondere Salze von schwachen organischen oder anorganischen Säuren, bevorzugt Kaliumcarbonat, Natriumtetraborat, Natriummetaborat. Auch kann man Mischungen aus Laugen und Salzen verwenden.For this purpose, one can simply use alkalis, preferably potassium hydroxide or sodium hydroxide. However, the pH can also be stabilized by salts of a weak acid in the desired alkaline range, in particular salts of weak organic or inorganic acids, preferably potassium carbonate, sodium tetraborate, sodium metaborate. You can also use mixtures of alkalis and salts.
Das Entwicklungsergebnis wird vorteilhaft beeinflusst, wenn man dem Entwickler zusätzlich ein Komplexierungsmittel zugibt. Es handelt sich hierbei bevorzugt um organische Säuren mit kleiner Kettenlänge, welche Stickstoffgruppen enthalten, nochmals bevorzugt zusätzlich kurze aliphatische Gruppen. Bevorzugte Komplexierungsmittel sind Diethyltriaminpentaethansäure (DTPA), Ethylendiamintetraethansäure (EDTA), Hydroxyethylethylendiamintriessigsäure (HEDTA) und Nitrilotriethansäure (NTA) sowie Salze der vorgenannten Säuren.The development result is advantageously influenced if the developer is additionally added a complexing agent. These are preferably organic acids with small chain length, which contain nitrogen groups, more preferably additionally short aliphatic groups. Preferred complexing agents are diethyltriamine pentaethanoic acid (DTPA), ethylenediaminetetraethanoic acid (EDTA), hydroxyethylethylenediaminetriacetic acid (HEDTA) and nitrilotriethanoic acid (NTA) and salts of the aforementioned acids.
Eine gebrauchsfertige Entwicklerlösung wird durch Oxidation in ihren Eigenschaften negativ beeinflusst. Zur Verbesserung der Langzeitstabilität eines gebrauchsfertigen Entwicklers gegen Oxidation kann man daher dem Entwickler ein Oxidationsschutzmittel zusetzen. Hierfür sind generell geeignet die nicht voll aufoxidierten Säuren und Salze derselben, insbesondere Sulfite wie Kaliumsulfit, Kaliumhydrogensulfit, Kaliummetabisulfit und Natriumhydrogensulfit.A ready-to-use developer solution is adversely affected by oxidation in its properties. To improve the long-term stability of a ready-to-use developer against oxidation, it is therefore possible to add an antioxidant to the developer. Suitable for this purpose are generally not completely oxidized acids and salts thereof, in particular sulfites such as potassium sulfite, potassium hydrogen sulfite, potassium metabisulfite and sodium bisulfite.
Zur besseren und gleichmäßigen Lösung des Entwicklungsmittels in dem Lösungsmittel kann ein Lösungsvermittler verwendet werden. Hierbei kann es sich um mehrwertige Alkohole, insbesondere Diole bzw. Glycole, handeln. Bevorzugt werden hier Diethylenglycol und Triethylenglycol verwendet.For a better and uniform solution of the developing agent in the solvent, a solubilizer can be used. These may be polyhydric alcohols, in particular diols or glycols. Diethylene glycol and triethylene glycol are preferably used here.
Schließlich wird die Qualität des Entwicklungsergebnisses auch durch ein Antischleiermittel verbessert. Besonders eignen sich Mittel, die zur Gruppe der Azole (insbesondere vom Typ Benzotriazol, vom Typ Indazol, vom Typ Mercaptotetrazol und vom Typ Imidazol) gehören, insbesondere 5-Mercapto-1-phenyl-1,2,3,4-tetrazol (PMT), 1-H-Benzotriazol, 5-Methylbenzotriazol, 6-Nitrobenzimidazol, 5-Nitroindazol.Finally, the quality of the development result is also improved by an antifoggant. Particularly suitable are agents belonging to the group of azoles (in particular of the benzotriazole, indazole, mercaptotetrazole and imidazole type), in particular 5-mercapto-1-phenyl-1,2,3,4-tetrazole (PMT ), 1-H-benzotriazole, 5-methylbenzotriazole, 6-nitrobenzimidazole, 5-nitroindazole.
Die nachstehenden Tabellen der Zusammensetzungen von Ausführungsbeispielen geben einen Überblick über die Konzentration, in welcher die verschiedenen Komponenten in einer Gebrauchslösung in Gramm pro Liter Gebrauchslösung vorliegen können.The tables below of the compositions of embodiments give an overview of the concentration in which the various components in a Use solution in grams per liter of working solution may be present.
Dabei sind jeweils die Konzentrationen angegeben, die empfohlen werden, wenn eine betrachtete Komponente allein das entsprechende Mittel bildet. Es versteht sich, dass man von Substanzen, die gleichermaßen für die gleiche Komponente des Entwicklers in Frage kommen, auch Mischungen verwenden kann, wobei dann die Einsatzmengen so gewählt werden, dass die entsprechende Gesamtwirkung erhalten wird. So ist zum Beispiel gemäß der folgenden Tabelle für die verschiedenen Komplexierungsmittel jeweils die selbe Einsatzmenge angegeben. In diesem Falle kann man dann einfach den weggelassenen Anteil eines Komplexierungsmittels durch eine entsprechende Menge eines anderen Komplexierungsmittels ersetzen.In each case, the concentrations are recommended, which are recommended if a considered component alone forms the corresponding agent. It is understood that it is also possible to use mixtures of substances that are equally suitable for the same component of the developer, in which case the amounts used are selected such that the corresponding overall effect is obtained. Thus, for example, according to the following table for the different complexing agents in each case the same amount used. In this case, one can then simply replace the omitted portion of a complexing agent with an appropriate amount of another complexing agent.
Für das pH-Einstellmittel sind dagegen die Einsatzmengen für die verschiedenen genannten Substanzen sehr unterschiedlich. Man erkennt, dass man zum Ersetzen einer vorgegebenen Menge an Natriumtretraborat eine Menge an Kaliumcarbonat verwenden muss, die etwas das sieben- bis neunfache der zu ersetzenden Menge Natriumtretraborat beträgt.For the pH adjusting agent, however, the amounts used for the various substances mentioned are very different. It will be appreciated that to replace a given amount of sodium tetraborate, one must use an amount of potassium carbonate that is about seven to nine times the amount of sodium tetraborate to be replaced.
Nachstehend werden bevorzugte praktische Ausführungsbeispiele für erfindungsgemäße Entwickler beschrieben.Hereinafter, preferred practical embodiments for developers according to the present invention will be described.
Die nachstehende Tabelle gibt unterschiedlich bevorzugte Bereiche für Komponenten eines erfindungsgemäßen Entwicklers an. Unterschiedliche Komponenten, die die gleiche Funktion haben können auch in Kombination verwendet werden, wobei die Mengen so angepaßt werden, das der gewünschte Gesamteffekt erhalten wird.
Die oben beschriebenen Entwickler der Beispiele 1 bis 4 wurden in einem Entwicklungsautomaten für Röntgenfilme getestet, der unter der Bezeichnung 'Dürr-Automat 24PRO' vermarktet wird. Es handelt sich hierbei um eine Rollenmaschine, in welcher die Röntgenfilme durch zusammenarbeitende Rollenpaare nacheinander durch einen Tank mit Entwicklerflüssigkeit, einen Fixiertank und einen Wässerungstank bewegt werden. Der Automat ist im wesentlichen allseitig geschlossen, steht jedoch über einen Filmeinlass-Schlitz und einen Filmauslass-Schlitz mit der Umgebungsatmosphäre in Verbindung.The above-described developers of Examples 1 to 4 were tested in an X-ray film developing machine marketed under the name 'Dürr Automat 24PRO'. This is a roller machine in which the X-ray films are moved by cooperating pairs of rollers successively through a tank with developer liquid, a fixing tank and a watering tank. The machine is substantially closed on all sides but communicates with the ambient atmosphere via a film inlet slot and a film outlet slot.
Im Dauerbetrieb wurden mit den oben beschriebenen Entwicklern Standzeiten von bis zu sechs Wochen erzielt.In continuous operation, the developers described above achieved service lives of up to six weeks.
Die Konzentrationsangaben in der obigen Beschreibung und den Ansprüchen beziehen sich, wie angegeben, auf einen Liter Gebrauchslösung und nicht auf das Konzentrat. Die Konzentrationen im Konzentrat sind gemäß dem vorgeschriebenen Verdünnungsverhältnis für das Konzentrat größer. Dieses Verdünnungverhältnis liegt für einen praktischen Entwickler für Rollen-Entwicklungsmaschinen bei etwa 1,5 zu 5, für rollenfreie Entwicklungsmaschinen (Film wird an den Rändern geführt durch die Tanks bewegt) bei etwa 0,5 zu 1.The concentration data in the above description and claims refer, as indicated, to one liter of working solution and not to the concentrate. The concentrations in the concentrate are greater according to the prescribed dilution ratio for the concentrate. This dilution ratio is about 1.5 to 5 for a practical developer for roll-fed development machines, and about 0.5 to 1 for roll-free processors (film is moved around the edges by the tanks).
Claims (28)
mit einem Einstellmittel, welches den pH-Wert des Lösungsmittels in alkalischen Bereich einstellt, und mit einem Entwicklungsmittel, dadurch gekennzeichnet, dass das Entwicklungsmittel Ascorbinsäure oder ein Salz der Ascorbinsäure umfasst und dass der pH-Wert so eingestellt ist, daß der pH-Wert der durch Verdünnen erhaltenen Gebrauchslösung zwischen etwa 8,5 und etwa 12 liegt.Developer concentrate for photosensitive film material with a water-based solvent,
with an adjusting agent which adjusts the pH of the solvent in the alkaline range, and with a developing agent, characterized in that the developing agent comprises ascorbic acid or a salt of ascorbic acid and that the pH is adjusted so that the pH of the by dilution use solution is between about 8.5 and about 12.
dadurch gekennzeichnet, dass das Salz der Ascor binsäure in einer Menge von etwa 15 g bis etwa 40 g, vorzugsweise etwa 22 g bis etwa 40 g, pro Liter Gebrauchslösung vorliegt.Developer concentrate according to one of claims 1 to 3,
characterized in that the salt of Ascor binsäure is present in an amount of about 15 g to about 40 g, preferably about 22 g to about 40 g, per liter of working solution.
dadurch gekennzeichnet, dass das Salz der Ascorbinsäure ein Alkali-Isoascorbat ist, insbesondere Natrium-Isoascorbat.Developer concentrate according to one of claims 1 to 4,
characterized in that the salt of ascorbic acid is an alkali isoascorbate, especially sodium isoascorbate.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006026422A DE102006026422A1 (en) | 2006-06-04 | 2006-06-04 | developer concentrate |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1862852A1 true EP1862852A1 (en) | 2007-12-05 |
EP1862852B1 EP1862852B1 (en) | 2009-11-04 |
Family
ID=38261701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07010793A Not-in-force EP1862852B1 (en) | 2006-06-04 | 2007-05-31 | Developer concentrate |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1862852B1 (en) |
AT (1) | ATE447727T1 (en) |
DE (2) | DE102006026422A1 (en) |
DK (1) | DK1862852T3 (en) |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993011456A1 (en) | 1991-12-02 | 1993-06-10 | E.I. Du Pont De Nemours And Company | Improved developer systems for hydrazine containing films |
JPH08211572A (en) | 1995-02-03 | 1996-08-20 | Fuji Photo Film Co Ltd | Image forming method |
US5587276A (en) | 1995-01-23 | 1996-12-24 | Fuji Photo Film Co., Ltd. | Image formation method |
JPH09197630A (en) | 1996-01-24 | 1997-07-31 | Fuji Photo Film Co Ltd | Developer for halogenated silver photographic material and developing method using this developer |
JPH09197628A (en) | 1996-01-24 | 1997-07-31 | Fuji Photo Film Co Ltd | Image forming method |
JPH09265161A (en) | 1996-01-24 | 1997-10-07 | Fuji Photo Film Co Ltd | Image forming method |
JPH09265162A (en) | 1996-01-24 | 1997-10-07 | Fuji Photo Film Co Ltd | Image forming method |
JPH10171076A (en) | 1996-02-07 | 1998-06-26 | Fuji Photo Film Co Ltd | Image forming method |
US5858611A (en) * | 1994-10-14 | 1999-01-12 | Fuji Photo Film Co., Ltd. | Development processing method of silver halide black-and-white photographic material |
EP0908764A1 (en) * | 1997-10-06 | 1999-04-14 | Agfa-Gevaert N.V. | Method of processing a black-and-white silver halide photographic material |
EP0969317A2 (en) * | 1998-07-01 | 2000-01-05 | Eastman Kodak Company | Method of processing a photographic high contrast silver halide material |
DE19834357A1 (en) * | 1998-07-30 | 2000-02-17 | Agfa Gevaert Ag | Photographic black-and-white processing with ascorbic acid or derivative in developer, useful for film and paper, uses oligophosphate in stop or stop-fix bath |
-
2006
- 2006-06-04 DE DE102006026422A patent/DE102006026422A1/en not_active Ceased
-
2007
- 2007-05-31 AT AT07010793T patent/ATE447727T1/en active
- 2007-05-31 DK DK07010793.3T patent/DK1862852T3/en active
- 2007-05-31 EP EP07010793A patent/EP1862852B1/en not_active Not-in-force
- 2007-05-31 DE DE502007001882T patent/DE502007001882D1/en active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993011456A1 (en) | 1991-12-02 | 1993-06-10 | E.I. Du Pont De Nemours And Company | Improved developer systems for hydrazine containing films |
US5858611A (en) * | 1994-10-14 | 1999-01-12 | Fuji Photo Film Co., Ltd. | Development processing method of silver halide black-and-white photographic material |
US5587276A (en) | 1995-01-23 | 1996-12-24 | Fuji Photo Film Co., Ltd. | Image formation method |
JPH08211572A (en) | 1995-02-03 | 1996-08-20 | Fuji Photo Film Co Ltd | Image forming method |
JPH09197630A (en) | 1996-01-24 | 1997-07-31 | Fuji Photo Film Co Ltd | Developer for halogenated silver photographic material and developing method using this developer |
JPH09197628A (en) | 1996-01-24 | 1997-07-31 | Fuji Photo Film Co Ltd | Image forming method |
JPH09265161A (en) | 1996-01-24 | 1997-10-07 | Fuji Photo Film Co Ltd | Image forming method |
JPH09265162A (en) | 1996-01-24 | 1997-10-07 | Fuji Photo Film Co Ltd | Image forming method |
JPH10171076A (en) | 1996-02-07 | 1998-06-26 | Fuji Photo Film Co Ltd | Image forming method |
EP0908764A1 (en) * | 1997-10-06 | 1999-04-14 | Agfa-Gevaert N.V. | Method of processing a black-and-white silver halide photographic material |
EP0969317A2 (en) * | 1998-07-01 | 2000-01-05 | Eastman Kodak Company | Method of processing a photographic high contrast silver halide material |
DE19834357A1 (en) * | 1998-07-30 | 2000-02-17 | Agfa Gevaert Ag | Photographic black-and-white processing with ascorbic acid or derivative in developer, useful for film and paper, uses oligophosphate in stop or stop-fix bath |
Also Published As
Publication number | Publication date |
---|---|
DE102006026422A1 (en) | 2007-12-06 |
DK1862852T3 (en) | 2010-03-22 |
ATE447727T1 (en) | 2009-11-15 |
EP1862852B1 (en) | 2009-11-04 |
DE502007001882D1 (en) | 2009-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2736886A1 (en) | METHOD OF TREATING LIGHT SENSITIVE COLOR PHOTOGRAPHIC SILVER HALOGENIDE RECORDING MATERIALS | |
DE2740322A1 (en) | COLOR PHOTOGRAPHIC DEVELOPMENT PROCESS | |
DE3029361C2 (en) | ||
DE2439153A1 (en) | PHOTOGRAPHIC BLEACH FIXING BATH | |
DE2343242A1 (en) | PROCESS FOR DEVELOPING EXPOSED PHOTOGRAPHICAL FILMS AND FOR REGENERATING THE DEVELOPER SOLUTION | |
DE2321400A1 (en) | PROCESS FOR DEVELOPING COLOR PHOTOGRAPHICAL MATERIALS | |
DE2803678A1 (en) | PROCEDURE FOR MAINTAINING EQUAL DEVELOPMENT ACTIVITY OF PHOTOGRAPHICAL DEVELOPERS | |
EP1862852B1 (en) | Developer concentrate | |
DE2527398A1 (en) | DEVELOPMENT PROCESS FOR LIGHT-SENSITIVE, PHOTOGRAPHIC SILVER HALOGENIDE MATERIALS | |
DE2936081A1 (en) | LIGHT SENSITIVE, PHOTOGRAPHIC SILVER HALOGENIDE RECORDING MATERIAL | |
DE1772123C2 (en) | Process for developing recording materials containing silver halide | |
DE2554528A1 (en) | BLEACH FIXER | |
DE2264986A1 (en) | DEVELOPER SOLUTION FOR COLOR INVERSION DEVELOPMENT OF PHOTOGRAPHICAL RECORDING MATERIALS CONTAINING AT LEAST ONE HALOGENSILVER EMULSION LAYER | |
DE2440610A1 (en) | PHOTOGRAPHIC RAPID DEVELOPER SOLUTIONS CONTAINING METAL CHELATE COMPOUNDS | |
DE945606C (en) | Photographic developer | |
DE3919551A1 (en) | Biodegradable bleach bath for photographic silver halide material - contg. ferric salt, chloride, persulphate, nitrate and hydroxy cpd. and/or amine | |
DE2137549C3 (en) | Process for the desilvering of photographic bleach-fix baths | |
DE69632885T2 (en) | Photographic conditioning solution containing polyaminocarboxylic acid as the sole antimicrobial agent and methods of use | |
DE19738120A1 (en) | Ascorbic acid developer for rapid development of photographic silver halide without excessive fogging | |
DE1622919A1 (en) | Photographic light-sensitive material | |
DE2129123A1 (en) | Developer solution for black and white and color development | |
DE2101436A1 (en) | Process for making material with dye images | |
DE19742490C1 (en) | Photographic black=and=white reversal developer free from hydroquinone | |
DE2449325C2 (en) | ||
DE1597488A1 (en) | Improved photographic emulsion for the production of direct positive images |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
17P | Request for examination filed |
Effective date: 20080112 |
|
17Q | First examination report despatched |
Effective date: 20080226 |
|
AKX | Designation fees paid |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: OROCHEMIE GMBH & CO. KG |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 502007001882 Country of ref document: DE Date of ref document: 20091217 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20091104 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100304 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100304 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100215 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100204 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20100805 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100205 |
|
BERE | Be: lapsed |
Owner name: OROCHEMIE G.M.B.H. & CO. KG Effective date: 20100531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100531 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20110131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100531 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20110531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100505 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100531 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20091104 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 447727 Country of ref document: AT Kind code of ref document: T Effective date: 20120531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120531 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 502007001882 Country of ref document: DE Representative=s name: WITTE, WELLER & PARTNER, DE Ref country code: DE Ref legal event code: R082 Ref document number: 502007001882 Country of ref document: DE Representative=s name: WITTE, WELLER & PARTNER PATENTANWAELTE MBB, DE |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20180518 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20190702 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20190531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190531 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 502007001882 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201201 |